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Problem: Biomedical literature and databases contain important clues for the identification of potential
disease biomarkers. However, searching these enormous knowledge reservoirs and integrating findings
across heterogeneous sources is costly and difficult. Here we demonstrate how semantically integrated
knowledge, extracted from biomedical literature and structured databases, can be used to automatically
identify potential migraine biomarkers.
Method: We used a knowledge graph containing more than 3.5 million biomedical concepts and 68.4
million relationships. Biochemical compound concepts were filtered and ranked by their potential as
biomarkers based on their connections to a subgraph of migraine-related concepts. The ranked results
were evaluated against the results of a systematic literature review that was performed manually by
migraine researchers. Weight points were assigned to these reference compounds to indicate their rela-
tive importance.
Results: Ranked results automatically generated by the knowledge graph were highly consistent with
results from the manual literature review. Out of 222 reference compounds, 163 (73%) ranked in the
top 2000, with 547 out of the 644 (85%) weight points assigned to the reference compounds. For refer-
ence compounds that were not in the top of the list, an extensive error analysis has been performed.
When evaluating the overall performance, we obtained a ROC-AUC of 0.974.
Discussion: Semantic knowledge graphs composed of information integrated from multiple and varying
sources can assist researchers in identifying potential disease biomarkers.
 2017 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Biomarker identification is a costly and difficult task due to the
rapid growth and fragmentation of biomedical knowledge
throughout biomedical literature and numerous databases.
Biomarkers are any substance, structure, or process that can be
measured in the body or its products and influence or predict
the incidence of outcome or disease [1]. They can be (epi)genetic,
proteomic, metabolomic, viral, bacterial, and visual [2,3].
Biomarkers have many applications, including the identification
of patient sub-populations, predicting drug efficacy/side effects,
and monitoring disease progression, which make biomarkeridentification a popular and important research topic [3–5]. Three
related factors make the identification of biomarkers a complex,
time-consuming and knowledge intensive task. First, the continu-
ous growth and fragmentation of knowledge simply overwhelms
researchers. For example PubMed, a key biomedical literature
resource, has grown from 17 million to over 23 million entries
in only eight years (at an exponential growth rate of 4 percent
per year) [6,7]. A similar development can be observed with the
size and number of biomedical databases [8–11]. Second, poten-
tial biomarkers are often not explicitly described as such in scien-
tific articles, especially in older literature. Often, the only
information reported is that the levels of a certain biomolecule
are increased or decreased in a certain disease state. Finally, bio-
marker identification is a task that must be repeated for different
diseases.
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tems would offer researchers considerable benefits in time and
effort. Such computational systems would also allow for easier
replication and comparison of research results. For biomedical lit-
erature, the most important knowledge reservoir, potential
biomarkers could be extracted with several literature mining tech-
niques such as: (a) co-occurrences, where non-specific co-
occurrences between compounds or genes or diseases are
extracted from the literature [12,13]; (b) rule-based, where rules
have to be defined manually and have a limited scope [14,15];
and (c) machine-learning techniques, which are dependent on
the availability of an annotated dataset for training a classifier
[16,17]. In the case of biomarker identification such a dependency
on training data is contradictory: to automatically extract
biomarkers using literature mining, saving time and effort, we
would first need to identify and extract a smaller but representa-
tive set of biomarkers manually for the training set, effectively
already reaching the goal of identifying and extracting biomarkers
by spending large amounts of time and effort. Instead, the
approach described in this paper is based on existing, structured
knowledge represented in a knowledge graph, whose creation is
not dependent on the prior availability of a training set (although
a reference set is naturally required to evaluate the results of
experiments afterwards). Another benefit of our approach is the
possibility to include both knowledge mined from literature, as
well as knowledge extracted from biomedical databases.
Our system represents knowledge as a graph composed of
unique biomedical concepts and their relationships. The minimal
unit of knowledge in this graph is a triple of two linked concepts
and their relationship (subject – predicate – object). The sources
(provenance) of each triple have also been included. By focusing
the knowledge graph’s representation of knowledge on individ-
ual concepts and their relationships we achieve an efficient
machine actionable integration of all structured knowledge. This
enables discovery of associations even when individual authors
do not mention them explicitly. For example, if article A states
that a particular compound is relevant for a disease, and article
B states that this compound can be found in blood, an integrated
representation in the knowledge graph enables automatic and
speedy identification of the disease-relevant compounds found
in blood.
This study aims to identify potential biochemical biomarker
compounds for migraine using a knowledge graph which contains
structured knowledge mined both from literature and from
biomedical databases.
We chose to focus on migraine-related biomarkers for multi-
ple reasons: (1) Migraine is a common, debilitating disease
which affects millions of people worldwide. The migraine diag-
nosis is based on symptoms, as there are no generally accepted
biomarkers for this disease [18]; (2) The pathogenesis of com-
mon migraine is largely unknown and, except for a few mono-
genetic subtypes, assumed to be multifactorial, which prevents
us from deriving potential biomarkers based on clear causal fac-
tors such as genes or biochemical pathways [19]; (3) Migraine
biomarkers are hypothesized to result in better pathophysiolog-
ical understanding, improved differentiation between different
headaches syndromes, prediction of treatment responses, or pre-
diction of future chronification of this disabling disorder [5]; (4)
Migraine is a well-researched disease in general, resulting in
many publications, which both enables and necessitates the
automated identification of potential biomarkers; (5)
Computer-aided literature research into migraine has a rich
history of knowledge discovery, first initiated by Swanson with
his literature based discovery of the relationship between
magnesium and migraine [20].2. Background
Previous studies have attempted to identify and extract
biomarkers from biomedical literature. Bravo et al. extracted
known biomarkers by mining all literature co-occurrences
between diseases and proteins or genes from Medline entries that
had been annotated with the ‘‘Biological Markers” MeSH heading.
They extracted 131,012 gene – disease associations, from which
11% were identified as biomarkers in DisGeNet [3]. Fleuren et al.
extended the CoPub tool to CoPubGene, to create a network of
gene-disease and gene-gene co-occurrences found in Medline
abstracts [21]. They used CoPubGene to describe the pathophysiol-
ogy underlying glucocorticoid-induced insulin resistance and to
identify genetic biomarkers, and manually investigated genes sug-
gested by their method. However, they did not label their results as
true-positive or false-positive, and did not compare their results to
a reference set. A drawback of both these methods is that they are
based on co-occurrences, which have a lower specificity when
compared to extracting triples with explicit predicates. A different
approach was taken by the developers of LiverCancerMarkerRIF.
They made an interface that highlights selected biomedical entities
in PubMed abstracts and allows experts to annotate potential
genetic biomarkers [22]. As this method relies on human annota-
tion, it still requires extensive manual effort. A self-organizing lit-
erature mining approach was developed for the InfoCodex system,
which was applied to identify diabetes and/or obesity biomarkers
[23]. They report precision values ranging from 1% to 59%, and
recall values of about 34% for their most reliable benchmarks.
However, this self-organization is highly dependent on training
data for training a classifier. KnowLife creates a knowledge graph
by automatically extracting knowledge directly from literature
and pharmaceutical resources such as Drugs.com, Medline, Wiki-
pedia Health and others, with the goal of providing users the most
recent information [24]. However, at the moment of writing no
publications about the practical application of KnowLife exist.
What all these approaches have in common is that they focus on
knowledge mined from literature and do not incorporate knowl-
edge from databases.
The Aetionomy project has developed NeuroRDF, which combi-
nes knowledge extracted from literature and databases to suggest
biomarker genes for Alzheimer’s disease [25]. As no reference set
was available, they performed literature studies to discuss their
top-ranked results, although they also did not label their results
as true-positive or false-positive. In addition to the development
of NeuroRDF, they performed an extensive review of available
knowledge graphs which are solely based on databases [26].
Another system named Biograph was also based on knowledge
extracted from databases only. The developers used 627 genes
known to be associated with 29 diseases within OMIM as a refer-
ence set [27]. They achieved an AUC (area under the receiver oper-
ating characteristics (ROC) curve) of 0.861. Furthermore, they
retrieved 22% of their reference set in the top 1% of their list of
results. Overall, as much knowledge relevant to our task is still rep-
resented in the literature, we consider graphs which include
knowledge extracted from literature to have a higher coverage.
Several companies, such as Ontotext and KNOESIS, offer seman-
tically integrated graph databases as a commercial service [28,29].
Euretos offers a knowledge graph, which is highly similar to ours,
with a workflow for biomarker identification [30]. A publically
accessible knowledge graph is provided by Ontotext’s LinkedLife-
Data, containing a large number of biomedical datasets, as well
as relationships mined from Medline [31]. Drawbacks of commer-
cial products are: (1) A lack of public availability. These are prod-
ucts which usually cannot be used without a (paid) license; (2) a
black-box character. It is uncommon for such commercial products
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available; and (3) a lack of control over the integration of addi-
tional datasets, and the methodology with which these are
integrated.
Existing, structured knowledge can be used for other tasks as
well. For example, Kang et al. demonstrated that use of a knowl-
edge graph for the extraction of adverse drug events from litera-
ture greatly reduced the size of the training corpus as compared
to a machine-learning approach [32]. For the same task Xu and
Wang showed that including existing knowledge improved the F-
score by 73% when compared to an SVM methodology [33]. Pons
et al. demonstrated in the recent BioCreative V challenge that the
use of a knowledge graph in literature mining increases perfor-
mance in compound–disease relationship extraction from litera-
ture [16].3. Materials and methods
Our approach for the identification of potential biomarkers and
the evaluation against a reference dataset is shown in Fig. 1. The
input consisted of two data items and ten subsequent steps. Four
steps were performed manually, with time requirements ranging
from short (migraine researchers needed about one working day
to define the migraine subgraph) to long (error analysis, multiple
weeks). This section will further describe the two data items and
the steps in the process.3.1. Graph database
In our knowledge graph, which runs on a 1.8.3 Neo4j graph
database, the 3,527,423 biomedical concepts are represented as
vertices, with 68,413,238 relationships between them. The individ-
ual concepts represent units of thought, which are atomic and
unique [34,35]. Two concepts can be connected to each other with
one or more semantic relationships (also referred to as predicates),
such as ‘‘causes” or ‘‘inhibits”, thereby forming a triple.
Concepts in the graph database are based on the 2012 AA ver-
sion of the Unified Medical Language System (UMLS) MetaThe-
saurus, which has been extended with concepts for proteins from
UniProt and genes from a previously created gene dictionary
[36,42]. New concepts were created for proteins and genes that
could not be mapped to UMLS concepts, while the terms and iden-
tifiers for proteins and genes that could be mapped to UMLS con-
cepts were added to their concepts. All concepts have been
categorized as one or more UMLS semantic types, and a single
semantic group, which are aggregations of semantic types
[37,38]. The added gene and protein concepts were manually
assigned to UMLS semantic types/groups.
The 171 unique relationships in the knowledge graph are based
on the relationships defined in the UMLS Semantic Network, the
relationships defined in the UMLS MetaThesaurus (MRREL table),
and the predicates used within Semantic Medline. Our approach
semantically integrates relationships extracted from Medline
abstracts as provided in Semantic Medline [39] with relationships
obtained from the UMLS [40], UniProt [41], the Comparative Toxi-
cogenomics Database [43], and from the datasets contained in
Linked Open Drug Data (LODD, consisting of DrugBank, DailyMed,
and SIDER [44]) into a single graph database. As the reference set
was the result of a structured literature review initiated in 2012,
we limited ourselves to integrating dataset versions from that year.
Semantic Medline is a set of triples created by the U.S. based
National Library of Medicine (who also host PubMed), by running
their relationship extraction tool SemRep on sentences from Med-
line titles and abstracts. UniProt contains annotations about indi-
vidual proteins, while the Comparative Toxicogenomics Databasecontains annotations about the influences of chemicals on diseases
and genes, as well as the relationships between genes and diseases.
The LODD datasets contain pharmacological data such as drug indi-
cations, ingredients, targets, and side effects.
The concepts and predicates in the Semantic Medline triples
were already expressed in terms of our ontology and predicate the-
saurus, and therefore did not require additional cross-mapping
effort [44,45]. For UniProt, the Comparative Toxicogenomics Data-
base, and the LODD databases the process for extracting relation-
ships between concepts included the manual mapping of the
implicit relations of the database schema to an explicit predicate
from our predicate-thesaurus. The mapping of the subject and
object from database records to the UMLS, UniProt or gene identi-
fiers in our ontology was performed by applying our Peregrine lit-
erature mining pipeline, which matched the subject or object to a
term or identifier associated with a concept [46]. An example of the
mapping of information from a UniProt record to concepts in our
ontology and relationships within our thesaurus is shown in
Appendix A.
The resulting relationships between the concepts, extracted
both from literature, database entries, and the UMLS are further
enriched by including references to the sources, also referred to
as the provenance of the relationships between two concepts.
These relationship sources can be references to articles that
describe the relationship, references to database entries, or refer-
ences to the Unified Medical Language System (UMLS)
Metathesaurus.
3.2. Reference set
For the reference set, a systematic literature review was per-
formed by two migraine researchers (R.M.D. and R.Z.) in accor-
dance with the Preferred Reporting Items for Systematic reviews
and meta-Analyses (PRISMA) statement, a reporting guideline for
systematic literature reviews [18]. Two searches were performed
on Medline, EMBASE, and Web of Science up to August 16, 2014
for published studies on biochemical findings in (1) blood, and
(2) cerebrospinal fluid (CSF) of migraine patients (see Appendix C
for queries) [47]. The two migraine researchers independently
assessed titles and abstracts to determine eligibility. Disagreement
was resolved by discussion. Subsequently, the same researchers
independently assessed full-text articles of potentially relevant
studies to verify if eligibility criteria were met and to evaluate
whether the results were adequately reported. Case-control stud-
ies in which one or more endogenous compounds (metabolites,
peptides, proteins) were quantified in blood or CSF of migraine
patients and non-migraine controls were included. An example of
the extracted data required to include a compound is provided in
Appendix B. An overview of the entire process has been provided
in Appendix E, and results for the CSF set have been published by
van Dongen et al. [18].
Not all potential biomarkers compounds identified by the sys-
tematic literature review were considered equally important. For
example, while some compounds were measured in multiple stud-
ies and showed significant difference between migraine patients
and controls, other compounds were only measured once in rela-
tion to migraine without a significant difference between migraine
patients and controls. As an easily interpretable metric of the
importance of a compound, each of them was assigned a weight
equal to the number of studies where a significant difference in
compound concentration in patient CSF or blood was found
according to the results of the structured literature review. The
weight points of the CSF and blood datasets were summed. The
result was a single, integrated set of compounds, with each com-
pound having a number of weight points as a measure of evidence.
With a total of 234 studies included in the literature review, the
Fig. 1. Overview of the various steps in this research. The light grey items (Knowledge graph and the Literature review results) are data items which were re-used (in
modified form) from other research [18,32]. Dark grey item are steps which have been performed manually. White items are steps which have been performed
computationally. The empty circle at the bottom of the figure indicates the end of the process.
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Fig. 2. Schematic representation of the migraine subgraph and potential biomark-
ers. The migraine subgraph consists of 58 migraine concepts (the hexagon in the
centre) and migraine-related concepts (white circles). The potential biomarkers
(grey triangles) are connected to the migraine subgraph.
Table 1
Overview of UMLS semantic types in the migraine subgraph.
Biologically active substance Chemical viewed structurally
Neuroreactive substance or biogenic
amine
Organic chemical
Hormone Nucleic acid, nucleoside, or
nucleotide
Enzyme Organophosphorus compound
Vitamin Amino acid, peptide, or protein
Immunologic factor Carbohydrate
Receptor Lipid
Disease or syndrome Steroid
Mental or behavioral dysfunction Eicosanoid
Body part, organ, or organ component Element, ion, or isotope
Tissue Physiologic function
Cell Organism function
Cell component Organ or tissue function
Gene or genome Cell function
Molecular function
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practice, the maximum summed weight was 25 points.
These compounds were subsequently manually mapped to
UMLS identifiers. If compounds could not be exactly mapped to a
term associated with a concept, a reasonable best fitting concept
was selected (e.g., ‘‘Total magnesium” was mapped to ‘‘magne-
sium”). Some compounds that were differentiated by the migraine
researchers, were considered synonymous in the UMLS (e.g., ‘‘L-
arginine” & ‘‘Arginine”, ‘‘Free Tryptophan” & ‘‘Tryptophan”), or
not specified to the same degree (conjugated and unconjugated
forms of a compound). These were considered to be duplicate
entries, and one of them was removed. If duplicates differed in
their weight points, the compound with the lowest number of
weight points was removed. As a result of this mapping process
one compound was removed from the CSF set, while ten com-
pounds were removed from the blood set. The ultimate set of ref-
erence compounds is available in the Supplemental Materials.
Some reference compounds had one or more direct relation-
ships with migraine, making them trivial to identify. To ensure that
our method was independent of this information, it did not make
use of such direct relationships between migraine and potential
biomarker compounds.
3.3. The migraine subgraph
The identification of potential biomarkers was based on a
migraine subgraph, where we defined a subgraph as a subset of
concepts and relationships within our knowledge graph. Cameron
et al. have also applied a subgraph-based methodology to recreate
Swanson’s original magnesium-migraine and Raynaud-fish oil dis-
coveries based on scientific literature, which illustrates a broader
trend for subgraph-based reasoning in biomedical knowledge
graphs for various tasks [49]. They used subgraphs in an attempt
to cluster paths consisting of specific predicates and intermediate
concepts between the diseases and compounds. Our subgraph-
based approach does not limit itself with such specific restrictions
on predicates and intermediate concepts, and thereby enables a
more holistic view of a disease where complex, cumulative interac-
tions between disease, physiology, genetics, and chemistry can
exist.
Our method searched outwards, starting from migraine con-
cepts, then going to subgraph concepts, to end at potential biomar-
ker compounds. A schematic representation of our model is shown
in Fig. 2. Migraine concepts were all concepts that contained the
word ‘‘migraine” in their label, that had a direct relationship with
the primary migraine concept (UMLS identifier C0149931), and
that belonged to the semantic type Disease or Syndrome. In total
58 migraine concepts adhered to these criteria. Our migraine sub-
graph was defined as the set of concepts that had a relationship
with one of the 58 migraine concepts, and that belonged to one
or more selected semantic types. Such a selection was necessary
because concepts in the UMLS (and therefore the knowledge
graph) range from highly specific enzymes to social behavior or
laboratory procedures. The selection of the semantic types for
the migraine subgraph was discussed and coordinated with the
migraine researchers. An overview of the selected semantic types
can be seen in Table 1. The migraine subgraph consisted of
migraine-associated diseases (e.g., epilepsy), for which some of
the compounds might have better described roles, as well as
pathophysiological processes (e.g., cortical spreading depression)
and anatomical structures [50–52]. The inclusion of the ‘‘Gene or
Genome” semantic type was motivated by the genetic components
of migraine, which have been extensively investigated [19]. Finally,
chemical concepts with one or more relationships to this subgraph
were retrieved. These chemical concepts were considered the
potential biomarkers.3.4. Ranking and filtering
To improve the performance of our method we took two filter-
ing steps, after which the potential biomarkers were ranked. This
process is also represented as pseudocode in Algorithms 1 & 2.
First, we removed 24 general concepts from both the subgraph
and the list of potential biomarkers, which were considered unin-
formative. These 24 concepts, which included concepts such as
‘‘Disease” or ‘‘Receptor” were manually identified.
Second, we removed non-endogenous compounds such as phar-
maceuticals from both the subgraph and the list of potential
biomarkers. Such compounds were identified by their assigned
semantic types, as they have mostly been classified with the
semantic type ‘‘Pharmacological Preparation”, combined with a
semantic type such as ‘‘Organic Chemical” or ‘‘Hormones”.
Finally, we ranked the list of potential biomarker compounds
based on the number of subgraph concepts they have a relation-
ship with, as represented in Fig. 2.
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#Inputs
 KG = Knowledge graph
 Subgraph = Set of migraine subgraph concepts
 Generic = Set of 24 manually selected highly generic
concepts
 It is questionable whether concepts’ current granularity is
always necessary.
 Irrelevant = Set of excluded (combinations of) semantic
types
#First filtering step
Foreach concept in Generic:
Remove concept from Subgraph, Candidates
#Second filtering step
Foreach concept in Subgraph, Candidates:
If semanticTypes(concept) in Irrelevant:
Remove concept from Subgraph, Candidates
#Ranking;
Foreach concept in Candidates:
Ranker[concept] = Count(Connections(concept,
Subgraph, KG))
Output = Order Candidates by Ranker
Return OutputAlgorithm 2: Connections function
#As our ranking method does not use predicates
between concepts, this query function only
returns unique combinations of subjects and
objects.
#Inputs:
 start: A candidate biomarker concept
 end: The set of subgraph concepts
 graph: A Knowledge graph in which the subject-predicate-
object triples are contained
Function Connections(start, end, graph):
Subjects, Predicates, Objects = graph.getTriples
(start, end)
Return Distinct(Subjects, Objects)0 
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Fig. 3. Histogram of the number of weight points assigned to the compounds. The
stacked bars represent CSF (grey) and blood (black).We also experimented with three other ranking mechanisms, which
are explained in Appendix D. Each of these alternative ranking
mechanisms used a different level of information of the knowledge
graph i.e. the edge-level, relationship-level, and provenance-level.
The resulting output of our method was a ranked list of poten-
tial biomarkers for the disease of interest. This ranking of potential
biomarkers was used as an indication for their relevance.
It should be noted that our knowledge graph also contains neg-
ative predicates. When two concepts are only connected by a neg-
ative predicate, we still considered this a valid relationship and
included it. Furthermore, we took no special action when two con-
cepts were connected with contradicting predicates, as these con-
tradictions have been found to be context dependent in 86% of the
cases in Semantic Medline [53].
3.5. Evaluation method
We evaluated the results of the subgraph-based method up to k
compounds with the metrics below, as it is unrealistic that userswill evaluate complete result sets generated by methods such as
ours [54]:
 Recall at k: The fraction of reference compounds found up to
rank k.
 Precision at k: The number of reference compounds identified
up to rank k, divided by k.
 Recall of weight points at k: The fraction of the total number of
assigned weight points found up to k.
 Cumulative gain: The gain expressed in points that a user gets
on average for every compound that is inspected, up to rank k.
Calculated by dividing the number of the weight points found
up to rank k by k.
In addition to the binary indications of the performance, such as
precision and recall at k, we present a user oriented measurement
of the performance with the Cumulative Gain. Not every result is
equally relevant, as illustrated by the weight points assigned to
the reference compounds. Järvelin and Kekäläinen have developed
the cumulative gain metric, which reasons from a user perspective.
Cumulative Gain quantifies the ‘‘gain” (in our case represented by
the weight points) a user obtains for every inspected result. It
thereby combines rank and relevance in a metric and is straightfor-
ward to interpret [55].
To evaluate the overall performance, we have plotted the com-
monly used ROC curve with the recall for the individual reference
compounds on the Y-axis (unweighted), and a curve with the recall
for the individual weight points on the Y-axis (weighted), with the
unique ranking values as discrimination thresholds. For the
weighted evaluation, the weights of the false-positive compounds
were set to 0. For both the weighted and unweighted curves we
calculated an AUC value.
4. Results
4.1. List of compounds from the systematic review
The reference set consisted of 61 CSF compounds and 200 blood
compounds. The total number of weight points assigned to CSF
compounds was 103 (average 1.7 per compound). The total num-
ber of weight points assigned to the blood compounds was 541
(average of 2.7 per compound). A histogram of the weight points
is shown in Fig. 3. The majority of the compounds has a weight
of 1, which indicates that only a single study reported their mea-
surement. Compounds with a higher number of weight points
were mostly found amongst the blood compounds.
Thirty-nine compounds were present in both subsets. Weight
points assigned to these compounds had a moderate correlation
Fig. 4. ROC plot of the generated results, when ranked on the number of subgraph
compounds connecting a potential biomarker compound with migraine. Both the
weighted (black) and unweighted (grey) results are shown. AUC values are 0.956 for
the unweighted evaluation, and 0.974 for the weighted evaluation.
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into a single set of 222 compounds with a combined weight of
644 points (average of 2.9 per compound).
4.2. Migraine subgraph & potential biomarker compound list
The migraine subgraph consisted of 1060 concepts, which we
categorized according to their semantic groups for brevity [37]. It
consisted of 460 Disorders, 351 Chemicals & Drugs, 105 Anatomy,
99 Physiology, and 58 Genes & Molecular Sequences concepts.
The list of potential biomarkers generated by our method con-
sisted of 51,409 extracted compounds, of which more than half
had the UMLS semantic type ‘Amino Acid, Peptide, or Protein’,
5684 the semantic type ‘Organic Chemicals’, and 5543 the seman-
tic type ‘‘Enzyme”, with the remainder of the semantic types found
less frequent. A complete list of all results is available in the Sup-
plemental Materials.
4.3. Evaluation
The list of potential biomarker compounds generated by our
method retrieves 201 of the 222 reference compounds (91%). We
chose to cut off the table at rank 2000, and present data for various
ranks of k up to that point, as shown in Table 2. From these 222 ref-
erence compounds, 163 reference compounds were ranked in the
top 2000 of the results list (73%). These reference compounds have
547 weight points assigned to them, out of a maximum of 644
weight points (85%).
To evaluate the overall performance we calculated a ROC plot
and its AUC values for both the weighted and the unweighted
results, as shown in Fig. 4. We achieved an AUC value of 0.956
for the unweighted plot, and an AUC value of 0.974 for the
weighted plot.
4.4. Location of reference compounds with direct relationship to
migraine within the ranking
As described in Section 3.3, the method did not use direct rela-
tionships between reference compounds and migraine. From the
222 reference compounds, 87 also have a direct relationship with
migraine. To establish where they were ranked, we inspected their
location on the list of generated results and calculated their meanTable 2
Evaluation metrics calculated for the results when ranked based on the number of
subgraph concepts connecting a potential biomarker compound to migraine.
k Recall
at k
Precision
at k
Recall of weight
points at k
Cumulative
gain
100 0.18 0.41 0.3 1.95
200 0.31 0.35 0.5 1.6
300 0.39 0.29 0.57 1.23
400 0.46 0.26 0.65 1.04
500 0.49 0.22 0.68 0.88
600 0.52 0.19 0.7 0.76
700 0.57 0.18 0.73 0.68
800 0.6 0.17 0.75 0.6
900 0.63 0.15 0.77 0.55
1000 0.64 0.14 0.79 0.51
1100 0.66 0.13 0.79 0.46
1200 0.67 0.12 0.8 0.43
1300 0.68 0.12 0.81 0.4
1400 0.69 0.11 0.82 0.38
1500 0.69 0.1 0.82 0.35
1600 0.7 0.1 0.82 0.33
1700 0.71 0.09 0.83 0.31
1800 0.72 0.09 0.84 0.3
1900 0.73 0.09 0.85 0.29
2000 0.73 0.08 0.85 0.27rank. The ranks and the distributions of all these compounds are
shown in Fig. 5, along with their mean rank (red triangle,
k = 497), and the top 1% of the 51,409 potential biomarker com-
pounds (dark blue rhombus, k = 514). The mean rank of the refer-
ence compounds with a direct connection is within the top 1% of
the list, with a considerable number of these reference compounds
ranked at the very top of the list. Furthermore, the blue shape indi-
cates that many reference compounds which only have an indirect
relationship to migraine in the knowledge graph are ranked simi-
larly high.
4.5. Error analysis
We performed an error analysis of the false-negative com-
pounds, i.e. the compounds that were not present within the list
of results, or that were found in the middle or the tail of the result
list. They were assigned to one of four error categories, as shown in
Table 3. Section 4.5.3 describes an error analysis of the false-
positive compounds among the top-100 compounds of the result
list.
4.5.1. Not present in result list
Our method did not retrieve 21 (11%) of the reference com-
pounds. One inclusion criterion was that compounds had to have
a relationship with our migraine subgraph. For 11 reference com-
pounds this was not the case, and they were therefore not found.
Further inspection showed that these were highly specific concepts
such as ‘‘6-oxo prostaglandin F1 alpha” or ‘‘para-hydroxymandelic
acids (unconjugated)”. For four out of these 11 compounds no rela-
tionship with another concept was available at all. The other seven
compounds only had manually assigned relationships from the
UMLSMetathesaurus with other concepts, but had no relationships
mined from literature or databases.
As described in Section 3.3, we only included compounds with
selected semantic types, and excluded non-endogenous (pharma-
cological) compounds. We find that 10 of the reference compounds
were excluded based on these criteria.
Fig. 5. Violin graph [56] of the density of reference compounds in the top 2000 compounds generated by the method. In this figure, reference compounds which also have a
direct relationship with migraine (red dots) are separated from the reference compounds which only have an indirect relationship with migraine (blue dots). The dot size
indicates the number of weight points assigned to the reference compound. The red and blue contours indicate the numeric density of reference compounds based on an
interval of 20 ranks. The red triangle shows the mean rank of the reference compounds which also have a direct relationship with migraine (k = 497), while the dark-blue
rhombus indicates 1% of the total number of generated results (k = 514). (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
Table 3
Categories of compounds we did not retrieve.
False-negatives n
Not present in result list 21
Too far away in graph 11
Excluded during filtering 10
Low on result list 38
Other reference compounds 24
Long-tail compounds 14
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We divided the generated list of 51,409 compounds in three
groups: (1) The top 2000 compounds, (2) A group in the ‘‘middle”
which we discuss below, and (3) the tail, which consisted of 37,938
compounds connected to migraine by only one or two concepts
from the migraine subgraph. Fourteen reference compounds were
part of the long tail. The relationships connecting them were
mostly manually assigned within the UMLS Metathesaurus. Upon
closer investigation, we identified two reference compounds that
were ranked low due to extraction errors, likely made during the
literature mining process for Semantic Medline. One of these com-
pounds was ‘‘Orexin A” (ranked at 20,728), which was incorrectly
mapped to the more general ‘‘Orexins” (which was ranked at
796) when extracted from the literature [57]. A similar error
caused the relatively row ranking of ‘‘homocysteine” (ranked at
5776), which was incorrectly mapped to ‘‘homocystine” during
the mining of the literature (ranked at 139) [58]. As an exhaustive
investigation of such literature mining errors was beyond the
scope of this article, it may well be that there were more of such
occurrences.
Twenty-four reference compounds were found in the ‘‘middle”
group described above, which means they were not ranked in the
top 2000 results, but had multiple relationships with other con-
cepts and had multiple sources associated with these relationships.
We examined whether their lower ranking was because they were
more weakly connected to the migraine subgraph, or whether this
was caused by them being connected to less concepts in general.
We found that for every concept in the migraine subgraph these
reference compounds were connected to, they were connected to
6.46 concepts in general. We compared these compounds with
the reference compounds we retrieved in the top 2000 of theresults, which were connected to 7.57 concepts for every subgraph
concept they were connected to. The lower ranked compounds
were therefore on average slightly more specifically connected to
the migraine-subgraph, by a factor 1.17. We can therefore conclude
that their lower ranking was caused by them being connected to
fewer concepts in general.
4.5.3. False-positives
Within the top 100 compounds, there were 59 false-positives.
From these, we identified two new potential biomarker com-
pounds which were ranked high by our method, and appeared to
fulfil the requirements of the systematic literature review: ‘‘argi-
pressin” and ‘‘estrogen” [59–61]. However, the migraine research-
ers considered these compounds to be the same as ‘‘vasopressin”
and ‘‘estradiol”, even though these are separate concepts within
the UMLS [40]. Similarly, five other compounds in the top of the list
were immediately recognizable as being (very) closely related to
compounds from the reference set (e.g. ‘‘the human form of the
TNF protein”). Another fourteen compounds should be subjected
to a separate evaluation, for example by performing a knowledge
discovery processes, which was beyond the scope of both the
structured literature review as well as this article [20].
5. Discussion
Our research demonstrates that the complex knowledge extrac-
tion task of biomarker identification is feasible when combining
structured knowledge with expert input. Additionally, the ranking
of potential biomarkers can be used to rapidly provide researchers
with a knowledge-based metric to prioritize biomarkers for further
research. When a reference set is not used, the only user input
which is required is to define the subgraph, which is a modest
amount of work, although it remains to be investigated whether
the methodology is generalizable for other diseases or extraction
tasks.
Our subgraph-based method, which identifies potential
migraine biomarkers from integrated knowledge sources, manages
to identify 73% of the reference compounds, with 85% of the weight
points in the top 2000 of the result list. When comparing our meth-
od’s performance to BioGraph, we achieve higher ROC-AUCs,
although this could be an artifact of the large number of false-
positives. While the cutoff of 2000 compounds seems high, assess-
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for the 6435 articles the migraine researchers had to screen for
their structured literature review, especially given our method’s
potential for further improvement such as using additional filters.
As previously mentioned, the reference set only includes com-
pounds which were measured in blood or CSF. As of yet our
methodology does not include such parameters. Our initial
attempts at filtering compounds, requiring them to have a relation-
ship to CSF or blood eliminated too many reference compounds
and decreased performance. By including a database such as the
Human Metabolome Database (HMDB), which contains knowledge
about which compounds can be found in CSF or blood, these filter-
ing capabilities can potentially be enhanced [62].
Based on our results, the sheer number of subgraph-concepts
connecting a potential biomarker compound to migraine can be
used as a high performing indicator of the strength of association.
While we tested another three ranking mechanisms, each using a
different level of information of the knowledge graph, performance
between these ranking mechanisms was roughly equal. We there-
fore chose to present the most intuitive and best performing rank-
ing mechanism in the article.
Our method failed to retrieve 21 of the 222 reference com-
pounds, while 38 compounds were ranked so low they were prac-
tically impossible to retrieve. For 6 of these 38 compounds the
chosen ranking mechanism is decisive whether they are in the
top 2000 results or not. For 14 out of these 38, the only associated
source was the UMLS Metathesaurus, making their retrieval on
the result list unrealistic. Furthermore, we showed that for at least
two of these compounds their low ranks were caused by extraction
errors, likely to be caused by mapping errors during the literature
mining process. For example, the false-positive concept ‘‘Orexins”
was ranked highly, while the true-positive ‘‘Orexin A” was ranked
in the tail of the list of results. Some false-positive concepts at high
ranks, such as ‘‘the human form of TNF-alpha”, were recognized to
be closely related to reference compounds. In two other cases the
migraine researchers considered two compounds synonymous,
even though this was not immediately obvious to a non-expert,
e.g. ‘‘Vasopressin” and ‘‘Argipressin”. Given these findings, it is
unclear whether the current granularity of the results provided by
the concepts is truly a requirement for users. It may be possible
to collapse closely related concepts with each other to condense
result lists. Such condensation of results would associate closely
related concepts with each other, thereby requiring users to inspect
fewer results without compromising the goal of their extraction
task. The term ‘‘scientific lens” has been proposed for this approach,
which allows different granularities of results for different user
requirements, e.g. when it may not be necessary to specify the con-
jugation status of a compound [63]. As future research, we intend to
investigate the impact of these scientific lenses on knowledge
extraction tasks. Finally, althoughwe use the reference set as a gold
standard, it is probably not perfect. Hence, it is conceivable that
some of the retrieved compounds not present in the reference set
are nonetheless potential biomarkers for migraine.
When assessing the direct relationships between migraine and
the reference compounds in the knowledge graph, we found them
to be incomplete. Less than half of the reference compounds had a
relationship with the migraine concepts, while all reference com-
pounds have been described as being related with migraine in
the literature. This discrepancy may have several causes: (1) insuf-
ficient annotations in databases, or the limitations of the literature
mining process. While for the manual process knowledge extrac-
tion was based on full-text articles, including tables and figures,
our process was based on knowledge extracted from individual
sentences in article abstracts and database annotations, which con-
tain much less information [48,64]; (2) not all articles used as
sources in the structured literature review were found in Medline,as shown in Appendix C; (3) Besides these technical issues, we
must consider the cognitive processes of the migraine researchers
when they were reading the articles for the literature review. They
might be able to summarize complex (transitive) relationships
required for biomarker identification into more direct relation-
ships, whereas a literature mining process separates such steps
(e.g. ‘‘A has a relationship with B, and B has a relationship with
C, therefore A and C may have a meaningful relationship” can be
determined by a human reader, but such meaningful inferences
are nontrivial to perform computationally). This creates a more
complex representation of the knowledge than the cognitive model
of the migraine researchers.
As future work we intend to investigate whether we can iden-
tify and leverage existing clusters of highly interconnected con-
cepts within the knowledge graph to use as more natural
subgraphs for these kinds of tasks. Furthermore, the influence of
scientific development and additional knowledge has not yet been
quantified. We therefore intend to repeat the experiment with
more recent knowledge, up until the last iteration of the systematic
literature review on 16 August 2014, and with more databases
integrated into the graph to measure how much results will differ.
This will allow us to quantify the value of additional knowledge for
knowledge extraction tasks.
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Appendix A. Example of mapping database record to triples
The challenge of integrating UniProt entries lies in mapping the
annotation fields to the corresponding ontology concepts. We used
our concept identification pipeline Peregrine to identify concepts
in the free text UniProt annotation fields [46]. The mapping of
the implicit relations defined in the UniProt keywords to the
proper semantic predicates is a one-time manual effort and
requires understanding of the biological meaning of the data. This
mapping process has been performed for all integrated databases.
An example of such mappings can be seen in Table 4. Once created
a mapping can be applied to each update of the database. The Uni-
Prot record also contains references to the sources for these anno-
tations (such as PubMed ID’s), which have been omitted from the
example table.
Appendix B. Example of source data in manual systematic
review
‘‘Results:We assessed plasma samples from 103 women with CM
[Chronic Migraine], 31 matched healthy women, 43 matched women
with EM [Episodic Migraine], and 14 patients with episodic cluster
headache matched for age. CGRP levels were significantly increased
in CM (74.90 pg/mL) as compared with control healthy women
(33.74 pg/mL), women with EM (46.37 pg/mL), and patients with epi-
sodic cluster headache (45.87 pg/mL).” Quote taken from Cernuda-
Morollón et al. [65].
Appendix C. Search strings for PubMed, EMBASE and Web of
Science
C.1. PubMed
C.1.1. Migraine AND Cerebrospinal fluid
(‘‘Migraine Disorders”[Mesh] OR ‘‘migraine”[all fields] OR ‘‘Sick
Headache”[all fields] OR ‘‘Migraineurs”[all fields] OR ‘‘Migraineur”
[all fields] OR ‘‘migrain⁄”[all fields]) AND (‘‘Cerebrospinal Fluid”
Fig. 6. Probability calculation based on edges between concepts. Here concept A
shares an edge with concepts B and C. If a traversal would be started at concept A,
the chance would be 0.5 for it to end up for both concept B and C.
Table 4
A mapping of some of the UniProt record fields for 14-3-3 protein beta/alpha to an RDF triple. This protein is mapped from the subject resource http://www.uniprot.org/uniprot/
P31946. The UniProt Keyword is manually mapped to the closest RDF thesaurus predicate. The Annotation field contents have been mapped to ontology concepts using the
Peregrine concept identification pipeline.
UniProt keyword Keyword mapped to predicate UniProt annotation Annotation mapped to
object
gene gene_product_encoded_by_gene YWHAB UMLS C1421558
GO - Molecular function gene_product_has_biochemical_function enzyme binding UMLS C1149286
GO - Molecular function gene_product_has_biochemical_function histone deacetylase binding UMLS C1323310
GO - Biological process gene_product_plays_role_in_biological_process activation of MAPKK activity UMLS C1155556
GO - Biological process gene_product_plays_role_in_biological_process epidermal growth factor receptor signalling
pathway
UMLS C1155379
Keywords - Biological process gene_product_plays_role_in_biological_process Host-virus interaction UMLS C0599952
Subcellular location location_of Cytoplasm UMLS C0010834
Keywords - Cellular component part_of Cytoplasm UMLS C0010834
Keywords - Cellular component part_of perinuclear region of cytoplasm UMLS C2253855
Keywords - Coding sequence
diversity
gene_product_has_abnormality Polymorphism UMLS C0032529
Organism conceptual_part_of Homo sapiens (Human) UMLS C0086418
Fig. 7. Probability calculation based on relationships between concepts. Here
concept A has one relationship with concept B, and three relationships with concept
C. If a traversal would be started at concept A, the chance of it ending at concept B
be would be 1/4 = 0.25, and 3/4 = 0.75 of it ending at concept C.
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ids”[all fields] OR ‘‘CSF”[all fields]).
C.1.2. Migraine AND Plasma/Serum
(‘‘Migraine Disorders”[Mesh] OR ‘‘migraine”[all fields] OR ‘‘Sick
Headache”[all fields] OR ‘‘Migraineurs”[all fields] OR ‘‘Migraineur”
[all fields] OR ‘‘migrain⁄”[all fields]) AND (‘‘Plasma”[Mesh] OR
‘‘Plasma”[all fields] OR ‘‘Plasmas”[all fields] OR ‘‘Plasm”[all fields]
OR ‘‘Serum”[Mesh] OR ‘‘Serum”[all fields] OR ‘‘Sera”[all fields] OR
‘‘Serums”[all fields] OR ‘‘Serologic”[all fields]).
C.2. EMBASE
C.2.1. Migraine AND Cerebrospinal fluid
(exp ‘‘Migraine”/OR ‘‘migraine”.mp OR ‘‘Sick Headache”.mp OR
‘‘Migraineurs”.mp OR ‘‘Migraineur”.mp OR ‘‘Migrain⁄”.mp) AND
(Cerebrospinal Fluid/OR Cerebrospinal Fluid.mp OR Cerebrospinal
Fluids.mp OR CSF.mp).
C.2.2. Migraine AND Plasma/Serum
(exp ‘‘Migraine”/OR ‘‘migraine”.mp OR ‘‘Sick Headache”.mp OR
‘‘Migraineurs”.mp OR ‘‘Migraineur”.mp OR ‘‘Migrain⁄”.mp) AND
((exp ‘‘Plasma”/ OR ‘‘Plasma”.mp OR ‘‘Plasmas”.mp OR ‘‘Plasm”.
mp) OR (exp ‘‘Serum”/ OR ‘‘Serum”.mp OR ‘‘Sera”.mp OR
‘‘Serums”.mp OR ‘‘Serologic”.mp)).
C.3. Web of science
C.3.1. Migraine AND Cerebrospinal fluid
TS = (Migraine OR Sick Headache OR Migraineurs OR Migrai-
neur OR Migrain⁄) AND TS = (Cerebrospinal Fluid OR Cerebrospinal
Fluids OR CSF).
C.3.2. Migraine AND Plasma/Serum
TS = (Migraine OR Sick Headache OR Migraineurs OR Migrai-
neur OR Migrain⁄) AND TS = (‘‘Plasma” OR ‘‘Plasmas” OR ‘‘Plasm”
OR ‘‘Serum” OR ‘‘Sera” OR ‘‘Serums” OR ‘‘Serologic”).
Appendix D. Alternative ranking mechanisms
In addition to ranking potential biomarkers based on the num-
ber of subgraph concepts it was connected to, we examine three
levels of information contained in the knowledge graph: (1) Edge
level, (2) Relationship level, (3) Source level.
An edge shared between two concepts can represent multiple
kinds of relationships (i.e. predicates) between concepts. Edges
thereby represent the generalization ‘‘has_semantic_relationship_with” of the specific predicates, and no two concepts are connected
by more than one edge. For example, both the predicate ‘‘associ-
ated with” and ‘‘causes” between two concepts are represented
by the same edge. The second level includes the explicit relation-
ships between two concepts such as ‘‘causes” or ‘‘stimulates” and
is therefore already more specific. The third level, which consists
of the sources underlying the relationships, is used similarly as
the second level.
Once all indirect paths between the migraine concept and the
potential biomarker have been retrieved, we calculate multiple
statistics to rank the potential biomarkers. These statistics are
based on two-step probability calculations, each using different
information from within these paths. We calculate the probability
through the migraine subgraph (step 1) to a potential biomarker
(step 2). The potential biomarkers are finally ranked based on the
combined chance.
Fig. 8. Probability calculation based on sources connecting concepts. Here concept
A has two sources connecting it with concept B, and 4 sources connecting it with
concept C. If traversal would be started at concept A, the chance of it ending at
concept B be 2/6 = 0.33, and 4/6 = 0.66 of it ending at concept C.
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follows:Potential biomarker relevancy
¼ sumðchance of step to subgraph conceptÞ
 sumðchance of step to potential biomarkerÞ(see Figs. 6–8)).Appendix E. Flowchart of systematic review processAppendix F. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.jbi.2017.05.018.References
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